HeiQ acquires industrial biotech Co for €7.5m
HeiQ Plc the newly listed textile innovation business, has acquired 51% of Chrisal N.V., Belgium for €7.5m (€5.0m in cash & €2.5m in shares). On completion, Chrisal will be renamed HeiQ Chrisal. Chrisal is a profitable industrial biotech company and a leader in innovative ingredients and consumer products that incorporate the benefits of probiotics and synbiotics. Chrisal reported revenues of €5.5m for the 12 months to 31 December 2020, up 62% on 2019, and an operating profit of €1.6m.
Below is an interview with HeiQ’s founders, filmed at its IPO in December 2020
HeiQ Investor Videos